Advertisement

Topics

Samsung Bioepis’s Biosimilar Trastuzumab First To Take On Roche’s Herceptin In EU

08:21 EDT 15 Sep 2017 | SCRIP

Samsung Bioepis’s Ontruzant is likely to be the first biosimilar to take on Roche’s Herceptin in the EU market after...

      

Related Stories

 

Original Article: Samsung Bioepis’s Biosimilar Trastuzumab First To Take On Roche’s Herceptin In EU

NEXT ARTICLE

More From BioPortfolio on "Samsung Bioepis’s Biosimilar Trastuzumab First To Take On Roche’s Herceptin In EU"

Quick Search
Advertisement
 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...